First–Episode Mania With Psychotic Features Triggered By Synthetic Cannabinoid Use: A Clinical Case Report

This clinical case report presents a 19-year-old male with a first-episode manic episode with psychotic features (ICD-10: F30.2), admitted to an acute psychiatric unit following a rapid onset of behavioral disorganization, insomnia, emotional lability, and psychotic symptoms. The patient had no prior psychiatric history but reported a background of childhood trauma, intermittent cannabis use since adolescence, and recent exposure to synthetic cannabinoids shortly before symptom escalation. Initial clinical assessment revealed euphoric mood, psychomotor agitation, thought acceleration, and disorganized behavior. Psychotic symptoms included visual misperceptions and grandiose ideation described as a “mental enlightenment.” The patient exhibited partial disorientation to time, emotional incongruence, and poor insight. Physical and neurological examinations were unremarkable. A toxicology screen confirmed the presence of THC and benzodiazepines, the latter administered during emergency intervention. An electrocardiogram showed normal sinus rhythm, and a psychological assessment supported a manic cognitive profile with elevated abstract reasoning and thought disorganization. Pharmacological treatment included intramuscular haloperidol and diazepam during the acute phase, followed by lithium carbonate (titrated to 1125 mg/day) and quetiapine (25 mg/day) for maintenance and stabilization. The patient’s condition improved steadily with resolution of psychotic symptoms, normalization of sleep and appetite and partial restoration of insight. The patient was discharged in a clinically stable state with recommendations for continued outpatient psychiatric care, mood monitoring, psychotherapy and substance use counseling. This case highlights the complex interplay of trauma, substance use, affective dysregulation and underscores the importance of early intervention, multimodal assessment and sustained treatment planning in first-episode mania with psychotic features.

Authors

Publication Details

Journal
Lithuanian University of Health Sciences
Published
2025-06-24
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First–Episode Mania With Psychotic Features Triggered By Synthetic Cannabinoid Use: A Clinical Case Report

Gabija Simanavičiūtė
Lithuanian University of Health Sciences
Cannabis and Cannabinoid Research
article

First–Episode Mania With Psychotic Features Triggered By Synthetic Cannabinoid Use: A Clinical Case Report

Gabija Simanavičiūtė
article en

Abstract

This clinical case report presents a 19-year-old male with a first-episode manic episode with psychotic features (ICD-10: F30.2), admitted to an acute psychiatric unit following a rapid onset of behavioral disorganization, insomnia, emotional lability, and psychotic symptoms. The patient had no prior psychiatric history but reported a background of childhood trauma, intermittent cannabis use since adolescence, and recent exposure to synthetic cannabinoids shortly before symptom escalation. Initial clinical assessment revealed euphoric mood, psychomotor agitation, thought acceleration, and disorganized behavior. Psychotic symptoms included visual misperceptions and grandiose ideation described as a “mental enlightenment.” The patient exhibited partial disorientation to time, emotional incongruence, and poor insight. Physical and neurological examinations were unremarkable. A toxicology screen confirmed the presence of THC and benzodiazepines, the latter administered during emergency intervention. An electrocardiogram showed normal sinus rhythm, and a psychological assessment supported a manic cognitive profile with elevated abstract reasoning and thought disorganization. Pharmacological treatment included intramuscular haloperidol and diazepam during the acute phase, followed by lithium carbonate (titrated to 1125 mg/day) and quetiapine (25 mg/day) for maintenance and stabilization. The patient’s condition improved steadily with resolution of psychotic symptoms, normalization of sleep and appetite and partial restoration of insight. The patient was discharged in a clinically stable state with recommendations for continued outpatient psychiatric care, mood monitoring, psychotherapy and substance use counseling. This case highlights the complex interplay of trauma, substance use, affective dysregulation and underscores the importance of early intervention, multimodal assessment and sustained treatment planning in first-episode mania with psychotic features.

Lithuanian University of Health Sciences
Good health and well-being
Openalex Percentile: Top 26%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.